Csaba Gajdos MD, FACS, FSSO (@csabagajdos1) 's Twitter Profile
Csaba Gajdos MD, FACS, FSSO

@csabagajdos1

Surgical Oncologist @UBSurgery | Professor @jacobs_me_ub | #SurgicalOutcomes | 🏒👨‍👩‍👦‍👦 l @asochat | @UABSurgery | @UMichSurgery

ID: 883827214126645249

linkhttps://medicine.buffalo.edu/faculty/profile.html?ubit=csabagaj calendar_today08-07-2017 23:16:43

238 Tweet

423 Followers

1,1K Following

Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

December Issue: Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with #ColonCancer at US News and World Report Ranked Versus Unranked Hospitals Abdullah Altaf, MD Timothy M. Pawlik Muhammad Muntazir Mehdi Khan rdcu.be/d19RN @csabagajdos1 Syed A. Ahmad

December Issue: Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with #ColonCancer at US News and World Report Ranked Versus Unranked Hospitals <a href="/AbdullahAltaf97/">Abdullah Altaf, MD</a> <a href="/timpawlik/">Timothy M. Pawlik</a> <a href="/Muntazirmehdik/">Muhammad Muntazir Mehdi Khan</a>

rdcu.be/d19RN

@csabagajdos1
<a href="/SyedAAhmad5/">Syed A. Ahmad</a>
Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

For discussion on the next #ASOchat : Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors rdcu.be/d7nFP Thursday, 1/30, 6:00 PM EST

Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

January Issue: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative #PeritonealMetastasis in pT4 #ColonCancer ? rdcu.be/d7HIj @jeffreyfarma Syed A. Ahmad

January Issue: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative #PeritonealMetastasis in pT4 #ColonCancer ?
 
rdcu.be/d7HIj

@jeffreyfarma
<a href="/SyedAAhmad5/">Syed A. Ahmad</a>
Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

Today, we will discuss PRRT for GEP-NETs from a surgeon’s perspective. What is the surgeon’s role prior to PRRT for patients with gastroenteropancreatic NETs? #ASOchat

Thor Halfdanarson (@oncothor) 's Twitter Profile Photo

Anthony Villano, MD Annals of Surgical Oncology Paging Stefano Partelli, my go-to expert on the subject. He led the NEOLUPANET phase 2 trial. Preoperative PRRT certainly safe and can be done but will it improve overall outcomes as well as resectability? With the ORR seen, certainly something to think about

<a href="/AMVillanoMD/">Anthony Villano, MD</a> <a href="/AnnSurgOncol/">Annals of Surgical Oncology</a> Paging <a href="/spartelli/">Stefano Partelli</a>,  my go-to expert on the subject. He led the NEOLUPANET  phase 2 trial.  Preoperative PRRT certainly safe and can be done but will it improve overall outcomes as well as resectability?  With the ORR seen, certainly  something to think about
Mike Wach MD (@mikewach_md) 's Twitter Profile Photo

Annals of Surgical Oncology James Howe Acknowledging it’s an uncommon manifestation, but has there been any experience with peritoneal metastases of NET? Does response to PRRT differ for those with peritoneal disease? Any role for debulking prior to PRRT? #ASOchat

Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

“Yes, both SBNET and PNET patients had statistically significant improvements in PFS with PRRT, and OS was very close in SBNET patients (P=0.06). Smaller numbers may have contributed.” - Dr. Howe (James Howe) #ASOchat

“Yes, both SBNET and PNET patients had statistically significant improvements in PFS with PRRT, and OS was very close in SBNET patients (P=0.06).  Smaller numbers may have contributed.” - Dr. Howe (<a href="/JamesHoweV/">James Howe</a>)
#ASOchat
NEJM (@nejm) 's Twitter Profile Photo

Our partnership with Dr. Glaucomflecken continues as he summarizes the final, 10-year outcomes of the CheckMate 067 trial, which investigated nivolumab plus ipilimumab in advanced melanoma. Access the article for free: nej.md/42V5Pps

NOREASTER STORM (@noreaster1816u) 's Twitter Profile Photo

18s wrapped up Nationals prep today. 1st game tomorrow in Pittsburgh at 515 vs Anaheim. Thank you to our sponsor john j fromen jr for supporting the team this year #rollstorm

18s wrapped up Nationals prep today. 1st game tomorrow in Pittsburgh at 515 vs Anaheim. Thank you to our sponsor <a href="/FroJr18/">john j fromen jr</a> for supporting the team this year #rollstorm
Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

#AudioVisualAbstract : Outcomes of Distal #RectalCancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection. yael Julio Garcia Aguilar rdcu.be/ewQz4 @csabagajdos1 Syed A. Ahmad